Cave, the founder of RMS subsidiary Pharm2Farm (P2F), had intended to call a general meeting over concerns about a GBP5mln fundraise announced last week by RMS and an accompanying warrant issue.
A virtual meeting today will address the issues highlighted by Cave, who has a near 18% stake in RMS.
Shares in the AIM-listed company have rocketed on its development of an anti-viral facemask, the production of which is expected to start early next year.
Cave said RMS’s broker SP Angel had set up the meeting and that constructive discussions are now taking place between the parties.
Shares in Remote Monitored were 5.3% higher at 1.29p.